|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6700 NOK | 0.00% |
|
-7.59% | -51.45% |
| 06-30 | Exact Therapeutics to Delist from Euronext Growth Oslo in October | MT |
| 06-26 | EXACT Therapeutics AS Gets Positive Safety Review For 60 ?l/Kg Dose In Phase 2 ENACT Trial | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 4.41M | - | - | - | - | - |
| 46.35B | |||||
| 40.13B | - | - | - | - | - |
| 36.33B | |||||
| 34.6B | |||||
| 26.77B |
- Stock Market
- Stocks
- EXTX Stock
- Charts EXACT Therapeutics
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
